Inventiva Adr stock is traded at $3.63, with a volume of 2,535,445. It is down -6.20% in the last 24 hours and up +4.91% over the past month. Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
Previous Close:
$3.87
Open:
$3.96
24h Volume:
2,535,445
Relative Volume:
1.00
Market Cap:
$857.53M
Revenue:
$4.90M
Net Income/Loss:
-$399.99M
P/E Ratio:
-
EPS:
-$2.84
Net Cash Flow:
-$122.90M
1W Performance:
-0.55%
1M Performance:
+4.91%
6M Performance:
-32.78%
1Y Performance:
-13.16%
1-Day Range:
$0.00$0.00
1-Week Range:
$3.55$4.27
52-Week Range:
$2.82$7.29
Inventiva Adr Stock (IVA) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS